Neamtu, Andrei; Mocci, Francesca; Laaksonen, Aatto; Silva, Fernando Luís Barroso da 
Source: Colloids and Surfaces B: Biointerfaces. Unidade: FCFRP
Subjects: COVID-19, MOLÉCULA, PROTOCOLOS CLÍNICOS, ELETROSTÁTICA, VIROLOGIA, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEAMTU, Andrei et al. Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants. Colloids and Surfaces B: Biointerfaces, v. 221, p. 1-10, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2022.112986. Acesso em: 22 jan. 2026.APA
Neamtu, A., Mocci, F., Laaksonen, A., & Silva, F. L. B. da. (2023). Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants. Colloids and Surfaces B: Biointerfaces, 221, 1-10. doi:10.1016/j.colsurfb.2022.112986NLM
Neamtu A, Mocci F, Laaksonen A, Silva FLB da. Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants [Internet]. Colloids and Surfaces B: Biointerfaces. 2023 ; 221 1-10.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.colsurfb.2022.112986Vancouver
Neamtu A, Mocci F, Laaksonen A, Silva FLB da. Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants [Internet]. Colloids and Surfaces B: Biointerfaces. 2023 ; 221 1-10.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.colsurfb.2022.112986
